30day notice

76124

Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices

Dated: September 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21024 Filed 9–16–24; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 30-Day Comment
Request; Stakeholder Measures and
Advocate Forms at the National Cancer
Institute (NCI)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide the
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health, National
Cancer Institute (NCI) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
SUMMARY:

Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to https://www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under 30-day

ADDRESSES:

31/2024, REVISION, National Cancer
Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information
Collection: This is a request for OMB to
approve the revision of the collection
titled ‘‘Stakeholder Measures and
Advocate Forms at the National Cancer
Institute (NCI)’’ for three additional
years of data collection. The Office of
Advocacy Relations (OAR) disseminates
cancer-related information to various
stakeholders, seeks input and feedback,
and facilitates collaboration to advance
NCI’s authorized programs. It is
beneficial for NCI, through the OAR, to
pretest strategies, concepts, activities,
and materials while they are under
development. Additionally,
administrative forms are necessary for
collecting demographic information and
areas of interest for advocates. Since
OAR is responsible for matching
advocates to NCI programs and
initiatives across the cancer continuum,
it is necessary to measure the
satisfaction of both internal and external
stakeholders with this collaboration.
This customer satisfaction research
helps ensure the relevance, utility, and
appropriateness of OAR and NCI’s many
initiatives and products. Past research
has enabled OAR to monitor stakeholder
trends, design and develop materials
based on user feedback, assess the
impact of activities, and improve service
delivery. Primary users are internal,
with some advocates providing contact
information, demographics, and prior
advocacy experience via a link provided
to them to input their data.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
17.

Review—Open for Public Comments’’ or
using the search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact Amy Williams, Director of the
Office of Advocacy Relations (OAR),
NCI, NIH, 31 Center Drive, Bldg. 31,
Room 10A28, MSC 2580, Bethesda, MD
20892, or call non-toll-free number 240–
781–3406, or email your request,
including your address, to
[email protected]. Formal requests
for additional plans and instruments
must be requested in writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on May 30, 2024, page 46894
(89 FR 46894) and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Cancer Institute (NCI), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection Title:
Stakeholder Measures and Advocate
Forms at the National Cancer Institute
(NCI), 0925–0774, Expiration Date10/

ddrumheller on DSK120RN23PROD with NOTICES1

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Number of
responses per
respondent

Average time
per response
(in hours)

Total
annual
burden
hour

Type of respondent

Form name

Individuals ..............................................
Individuals ..............................................
Individuals ..............................................

Advocates Survey .................................
Requestor Survey .................................
Profile Completion .................................

6
6
30

1
1
1

5/60
5/60
30/60

1
1
15

Total ................................................

................................................................

......................

42

........................

17

VerDate Sep<11>2014

17:12 Sep 16, 2024

Jkt 262001

PO 00000

Frm 00060

Fmt 4703

Sfmt 9990

E:\FR\FM\17SEN1.SGM

17SEN1

Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices
Dated: September 11, 2024.
Melissa M. Park,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2024–21059 Filed 9–16–24; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting

ddrumheller on DSK120RN23PROD with NOTICES1

Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: October 30, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, 3G54, Rockville,
MD 20892 (Video Assisted Meeting).
Contact Person: Hitendra S. Chand, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G54, Rockville, MD
20892, (240) 627–3245, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HOMELAND
SECURITY

National Institutes of Health

Transportation Security Administration

National Institute of Nursing Research;
Notice of Closed Meetings

Intent To Request Extension From
OMB of One Public Collection of
Information: Exercise Information
System

Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel:
NINR R25 Applications.
Date: October 17, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, 6700B Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Nisan Bhattacharyya,
Ph.D., Scientific Review Officer, Scientific
Review Branch, NIDCR, NIH, 6701
Democracy Boulevard, Suite 668, Bethesda,
MD 20892, 301–451–2405,
[email protected].
Name of Committee: National Institute of
Nursing Research Initial Review Group.
Date: October 22, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, 6700B Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Joshua R Wolff, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, 6701 Democracy Boulevard,
Bethesda, MD 20817, (301) 793–5758,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: September 12, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.

Dated: September 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2024–21122 Filed 9–16–24; 8:45 am]

[FR Doc. 2024–21023 Filed 9–16–24; 8:45 am]

BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

VerDate Sep<11>2014

17:12 Sep 16, 2024

Jkt 262001

76125

PO 00000

Frm 00061

Fmt 4703

Sfmt 4703

Transportation Security
Administration, DHS.
ACTION: 60-Day notice.
AGENCY:

The Transportation Security
Administration (TSA) invites public
comment on one currently approved
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0057,
abstracted below that we will submit to
the Office of Management and Budget
(OMB) for an extension in compliance
with the Paperwork Reduction Act. The
ICR describes the nature of the
information collection and its expected
burden for the TSA Exercise
Information System (EXIS®). EXIS® is a
web portal that assists stakeholders to
build and manage exercise planning
teams, and share best practices &
lessons learned. Using and inputting
information into EXIS® is completely
voluntary.
DATES: Send your comments by
November 18, 2024.
ADDRESSES: Comments may be emailed
to [email protected] or delivered to the
TSA PRA Officer, Information
Technology (IT), TSA–11,
Transportation Security Administration,
6595 Springfield Center Drive,
Springfield, VA 20598–6011.
FOR FURTHER INFORMATION CONTACT:
Christina A. Walsh at the above address,
or by telephone 571–227–2062.
SUPPLEMENTARY INFORMATION:
SUMMARY:

Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation will be
made available at https://
www.reginfo.gov upon its submission to
OMB. Therefore, in preparation for
OMB review and approval of the
following information collection, TSA is
soliciting comments to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;

E:\FR\FM\17SEN1.SGM

17SEN1